| Identification | Back Directory | [Name]
PRAZARELIX | [CAS]
134457-28-6 | [Synonyms]
Azaline B PRAZARELIX Prazarelix [inn] D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-4-[(3-amino-1H-1,2,4-triazol-5-yl)amino]-L-phenylalanyl-4-[(3-amino-1H-1,2,4-triazol-5-yl)amino]-D-phenylalanyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl- | [Molecular Formula]
C80H102ClN23O12 | [MDL Number]
MFCD06407662 | [MOL File]
134457-28-6.mol | [Molecular Weight]
1613.27 |
| Chemical Properties | Back Directory | [density ]
1.348±0.06 g/cm3(Predicted) | [pka]
11.55±0.40(Predicted) | [Sequence]
Ac-{d-Ala<2Nal>}-{d-Phe}-{d-Ala}-Ser-{Phe}-{d-Phe}-Leu-{Lys}-Pro-{d-Ala} X=3-amino-1H-1,2,4-triazol-5-yl)amino |
| Hazard Information | Back Directory | [Uses]
Azaline B is an antagonist for gonadotropin-releasing hormone (GnRH) with IC50 of 1.37 nM, Azaline B can be used in research of sex hormone-related pathological states, ovulation induction and male contraception[1]. | [References]
[1] Samant MP, et al., Novel gonadotropin-releasing hormone antagonists with substitutions at position 5. Biopolymers. 2005;80(2-3):386-91. DOI:10.1002/bip.20195 |
|
|